James Posey
Impact in
Papers in
- Oncology 34
- Colorectal Cancer Treatments and Studies 12
- Pancreatic and Hepatic Oncology Research 10
- Cancer Treatment and Pharmacology 7
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Matthew H. Kulke (4 shared papers)Neal J. Meropol (3 shared papers)Heinz‐Josef Lenz (4 shared papers)Charles S. Fuchs (2 shared papers)Joel Picus (2 shared papers)Keith Stuart (2 shared papers)Emily K. Bergsland (2 shared papers)Charles M. Baum (2 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Cancer Chemotherapy and Pharmacology (4 papers)European Journal of Cancer (2 papers)Cancer Biotherapy and Radiopharmaceuticals (2 papers)Cancer (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
James Posey
64 papers receiving 2.7k citations
James Posey's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.4k
- Neurology 493
- Epidemiology 929
- Hepatology 147
- Cancer Research 276
Countries citing papers authored by James Posey
This map shows the geographic impact of James Posey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Posey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Posey more than expected).
Fields of papers citing papers by James Posey
This network shows the impact of papers produced by James Posey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Posey. The network helps show where James Posey may publish in the future.
Co-authors
The 25 scholars most cited alongside James Posey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial Hit paper breakdown → | 2009 | 519 |
| 2 | Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors Hit paper breakdown → | 2008 | 482 |
| 3 | 2001 | 162 | |
| 4 | 2010 | 117 | |
| 5 | A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. | 2003 | 106 |
| 6 | 2016 | 89 | |
| 7 | A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors. | 2002 | 89 |
| 8 | 2007 | 84 | |
| 9 | 2016 | 81 | |
| 10 | 2017 | 81 | |
| 11 | 2009 | 75 | |
| 12 | 2016 | 67 | |
| 13 | 2010 | 64 | |
| 14 | 2009 | 61 | |
| 15 | 2005 | 61 | |
| 16 | 2004 | 60 | |
| 17 | 2005 | 47 | |
| 18 | 2019 | 46 | |
| 19 | NCCN Practice Guidelines for Colorectal Cancer. | 2000 | 46 |
| 20 | 2010 | 38 |
About James Posey
James Posey is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 67 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Pancreatic and Hepatic Oncology Research (10 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Treatment and Pharmacology (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Esophageal Cancer Research and Treatment (5 papers), Neuroendocrine Tumor Research Advances (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (1.4k citations), Neurology (493 citations), Epidemiology (929 citations), Hepatology (147 citations) and Cancer Research (276 citations). James Posey has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Matthew H. Kulke, Neal J. Meropol, Heinz‐Josef Lenz, Charles S. Fuchs, Joel Picus, Keith Stuart, Emily K. Bergsland, Charles M. Baum, David P. Ryan and Mansoor N. Saleh. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, European Journal of Cancer, Cancer Biotherapy and Radiopharmaceuticals and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.